Reference40 articles.
1. Moncada, S., Gryglewski, R.J., Bunting, S. and Vane, J.R. (1976). An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (London), 263, 663–665
2. Siegl, A.M., Smith, J.B., Silver, M.J., Nicolaou, K.C. and Ahern, D. (1979). Selective binding site for [3H]prostacyclin on platelets. J. Clin. Invest., 63, 215–220
3. Lombroso, M., Nicosia, S., Paoletti, R., Whittle, B.J.R., Moncada, S. and Vane, J.R. (1984). The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes. Prostaglandins, 17, 321–333
4. Miller, O.V. and Gorman, R.R. (1979). Evidence for distinct prostaglandin I2 and D2 receptors in human platelets. J. Pharmacol. Exp. Ther., 210, 134–140
5. Hall, J.M. and Strange, P.G. (1984). The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells. Biosci. Rep., 4, 941–948
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug receptors and control of the cardiovascular system: Recent advances;Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques;1991